John Lee Welborn, Director at HLS Therapeutics Inc, holds 99.10K shares in HLS Therapeutics Inc (Ticker: TSE:HLS). Most recently, John Lee Welborn Bought C$2,100 shares of HLS Therapeutics Inc on Dec 17, 2024 for an estimated value of 6.83K.
What is the percentage of profitable transactions made by John Lee Welborn?
The percentage of profitable transactions made by John Lee Welborn is 50%.
What is the average return per transaction made by John Lee Welborn?
The average return per transaction made by John Lee Welborn is -18.80%.
What stocks does John Lee Welborn hold?
John Lee Welborn holds: TSE:HLS stocks.
What was John Lee Welborn’s latest transaction?
John Lee Welborn latest transaction was an Informative Buy of C$6.83K.
What was John Lee Welborn's most profitable transaction?
John Lee Welborn’s most profitable transaction was an Informative Buy of TSE:HLS stock on December 17, 2024. The return on the trade was 6.60%.
What is John Lee Welborn's role in HLS Therapeutics Inc?
John Lee Welborn's role in HLS Therapeutics Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.